This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
BUZDAR, AMAN U
| Item Type | Name |
|
Academic Article
|
Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
|
|
Academic Article
|
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials.
|
|
Academic Article
|
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.
|
|
Concept
|
Estrogen Antagonists
|
|
Academic Article
|
Aromatase inhibitors: current status.
|
|
Academic Article
|
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
|
|
Academic Article
|
Update on endocrine therapy for breast cancer.
|
|
Academic Article
|
Tamoxifen versus aromatase inhibitors for breast cancer prevention.
|
|
Academic Article
|
Phase II evaluation of Ly156758 in metastatic breast cancer.
|
|
Academic Article
|
Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCL, in metastatic breast cancer.
|
|
Academic Article
|
Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
|
|
Academic Article
|
Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer.
|
|
Academic Article
|
Fulvestrant--a novel estrogen receptor antagonist for the treatment of advanced breast cancer.
|
|
Academic Article
|
Anastrozole.
|
|
Academic Article
|
Current status of endocrine treatment of carcinoma of the breast.
|
|
Academic Article
|
Trioxifene mesylate in the treatment of advanced breast cancer.
|
|
Academic Article
|
Phase I trial of droloxifene in patients with metastatic breast cancer.
|
|
Academic Article
|
Preliminary data from ongoing adjuvant aromatase inhibitor trials.
|
|
Academic Article
|
Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.
|
|
Academic Article
|
Combination endocrine therapy in the management of breast cancer.
|
|
Academic Article
|
Distribution of (7alpha)-21-[4-[(diethylamino) methyl]-2-methoxyphenoxy]-7-methyl-19-norpregna-1,3,5(10)-trien-3-ol-20-[14C]2-hydroxy-1,2,3-propanetricarboxylate ([14C]TAS-108) and its metabolites after single oral administration to rats bearing 7,12-dimethylbenz(alpha)anthracene-induced mammary tumor.
|
|
Academic Article
|
Combination endocrine treatments unproven in breast cancer.
|
|
Academic Article
|
Differences in toxicity findings for antiestrogens.
|
|
Academic Article
|
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
|